Tilray Inc (NASDAQ:TLRY – Get Free Report) shares traded down 0% during mid-day trading on Thursday . The company traded as low as $1.70 and last traded at $1.72. 6,963,217 shares traded hands during mid-day trading, a decline of 72% from the average session volume of 25,180,400 shares. The stock had previously closed at $1.72.
Tilray Price Performance
The stock’s 50-day moving average is $1.82 and its 200 day moving average is $1.87. The company has a quick ratio of 1.42, a current ratio of 2.27 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $1.47 billion, a PE ratio of -3.95 and a beta of 2.13.
Tilray (NASDAQ:TLRY – Get Free Report) last posted its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The company had revenue of $229.90 million during the quarter, compared to analyst estimates of $226.20 million. Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business’s revenue for the quarter was up 24.8% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.15) earnings per share. As a group, equities analysts predict that Tilray Inc will post -0.15 earnings per share for the current year.
Institutional Trading of Tilray
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Further Reading
- Five stocks we like better than Tilray
- 5 Top Rated Dividend Stocks to Consider
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- Investing in Travel Stocks Benefits
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- What is Insider Trading? What You Can Learn from Insider Trading
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.